QWM
REGN icon

Quaker Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quaker Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Hold
2
– – ﹤0.01% 533
2026
Q1 		$1.55K Hold
2
– – ﹤0.01% 456
2025
Q4 		$1.54K Buy
2
+1
+100% +$679 ﹤0.01% 478
2025
Q3 		$563 Sell
1
-1
-50% -$565 ﹤0.01% 575
2025
Q2 		$1.05K Buy
+2
New +$1.12K ﹤0.01% 481

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Quaker Wealth Management's REGN Position: Q2 2026 in Review

Quaker Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 2 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Quaker Wealth Management first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.55K in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Quaker Wealth Management held 2 shares of Regeneron Pharmaceuticals worth $1.25K as of Q2 2026.
  • Quaker Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #533 holding.
  • Quaker Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Regeneron Pharmaceuticals position peaked at $1.55K in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.